• Angiotech Develops Product to Reduce Vascular Graft Failures
  For those unfamiliar, hemodialysis is a method of filtering waste from a patient’s blood when their kidneys are no longer able to function. But before a patient can undergo hemodialysis, a vascular graft must be implanted in order to allow a connection
  Vancouver based Angiotech Pharmaceuticals Inc., plans to aid hemodialysis patients with their new vascular graft technology that will soon begin ...
  in Public bookmarks with biotech biotechnology bioscience news canada angiotech kidney vascular graft pharmaceuticals hemodialysis

hemodialysis from all users